Currently, aHUS pathogenesis is believed to be primarily attributed to genetic variants in complement regulatory proteins or complement intrinsic proteins, or the presence of anti-complement factor H (CFH) antibodies. This evidence concerns the gene CFH and atypical hemolytic-uremic syndrome.